Acute myocardial ischemia after high-dose therapy with BEAM regimen

Bone Marrow Transplant. 2002 Aug;30(4):253-4. doi: 10.1038/sj.bmt.1703632.

Abstract

We describe a case of acute myocardial ischemia following carmustine treatment during the BEAM regimen. Despite this, full completion of the autologous peripheral stem-cell transplant was possible.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carmustine / administration & dosage
  • Carmustine / adverse effects*
  • Cytarabine / administration & dosage
  • Disease-Free Survival
  • Etoposide / administration & dosage
  • Female
  • Humans
  • Immunoblastic Lymphadenopathy / complications
  • Immunoblastic Lymphadenopathy / therapy
  • Melphalan / administration & dosage
  • Middle Aged
  • Myocardial Ischemia / chemically induced*
  • Peripheral Blood Stem Cell Transplantation
  • Transplantation, Autologous

Substances

  • Cytarabine
  • Etoposide
  • Melphalan
  • Carmustine

Supplementary concepts

  • BEAM regimen